Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples

Gravina,Giovanni  Luca; Mancini,Andrea; Ranieri,Guido; Di Pasquale,Boris; Marampon,Francesco; Di Clemente,Luigi; Ricevuto,Enrico; Festuccia,Claudio

doi:10.3892/ijo.2013.1892

Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples

Authors:
- Giovanni Luca Gravina
- Andrea Mancini
- Guido Ranieri
- Boris Di Pasquale
- Francesco Marampon
- Luigi Di Clemente
- Enrico Ricevuto
- Claudio Festuccia
View Affiliations

Affiliations: Department of Biotechnological and Applied Clinical Sciences, Laboratory of Radiobiology, University of L'Aquila, L'Aquila, Italy, Department of Biotechnological and Applied Clinical Sciences, Division of Radiation Oncology, University of L'Aquila, L'Aquila, Italy, Division of Urology, Ospedale San Salvatore L'Aquila, L'Aquila, Italy, Department of Biotechnological and Applied Clinical Sciences, Division of Medical Oncology, University of L'Aquila, L'Aquila, Italy
Published online on: April 10, 2013 https://doi.org/10.3892/ijo.2013.1892
Pages: 2116-2122

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Emerging evidence has shown that the tumor microenvironment plays a crucial role in prostate cancer (PCa) development and progression. However, the mechanism(s) through which stromal cells regulate epithelial cells and the differences among prostatic stromal cells of different histological/pathological origin in PCa progression remain unclear. Therefore, it is necessary to characterize the stromal cell populations present in benign prostatic hyperplasia (BPH) and PCa. To this end, we used cultures from stromal cells obtained from BPH-derived (15 cases) and PCa-derived (30 cases) primary cultures. In culture, stromal cells are a mixture of fibroblasts, myofibroblasts (MFs) and muscle cells. Fibroblasts are characterized for the expression of vimentin, MFs for the co-expression of α-smooth muscle actin (α-SMA) and vimentin, whereas muscle cells for the expression of α-SMA and desmin. Fibroblasts were present in large amounts in the BPH- compared to the PCa-derived cultures, whereas MFs were more representative of PCa- as opposed to BPH-derived cultures. Some α-SMA-positive cells retained the expression of basal cytokeratin K14. This population was defined as myoepithelial cells and was associated with senescent cultures. The percentage of MFs was higher in high-grade compared to moderate- and low-grade PCa-derived cultures, whereas the number of myoepithelial cells was lower in high-grade compared to moderate- and low-grade PCa-derived cultures. In addition, we analyzed the expression of p75NTR, as well as the expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitors of MMPs (TIMPs). p75NTR expression was elevated in the stromal cultures derived from PCa compared to those derived from BPH and in cultures derived from cases with Gleason scores ≥7 compared to those derived from cases with Gleason scores <7, as well as in cultures with a high concentration of MFs compared to those with a high concentration of fibroblasts. MMP-2 was secreted by all primary cultures, whereas MMP-9 secretion was observed only in some PCa-derived stromal cells, when the percentage of MFs was significantly higher compared to BPH-derived cultures. TIMP1, TIMP2 and TIMP3 were secreted in elevated amounts in the BPH- compared to the PCa-derived stromal cultures, suggesting the differential regulation of extracellular matrix (ECM) degradation. When we used 22rv1 and PC3 PCa xenograft models for the isolation and characterization of murine cancer-associated fibroblasts (CAFs) we noted that the angiogenic wave was concurrent with the appearance of a reactive stroma phenotype, as determined by staining for α-SMA, vimentin, tenascin, calponin, desmin and Masson's trichrome. In conclusion, MF stromal cells from PCa participate in the progression and metastasis of PCa, modualting inflammation, angiogenesis and epithelial cancer cell proliferation.

View Figures

View References

1	Barron DA and Rowley DR: The reactive stroma microenvironment and prostate cancer progression. Endocr Relat Cancer. 19:R187–R204. 2012. View Article : Google Scholar : PubMed/NCBI
2	Ammirante M, Luo JL, Grivennikov S, Nedospasov S and Karin M: B-cell-derived lymphotoxin promotes castration-resistant prostate cancer. Nature. 464:302–305. 2010. View Article : Google Scholar : PubMed/NCBI
3	Iacopino F, Angelucci C and Sica G: Interactions between normal human fibroblasts and human prostate cancer cells in a co-culture system. Anticancer Res. 32:1579–1588. 2012.PubMed/NCBI
4	Grubisha MJ, Cifuentes ME, Hammes SR and Defranco DB: A local paracrine and endocrine network involving TGFβ, Cox-2, ROS, and estrogen receptor β influences reactive stromal cell regulation of prostate cancer cell motility. Mol Endocrinol. 26:940–954. 2012.PubMed/NCBI
5	Hayward SW, Wang Y, Cao M, Hom YK, Zhang B, Grossfeld GD, Sudilovsky D and Cunha GR: Malignant transformation in a nontumorigenic human prostatic epithelial cell line. Cancer Res. 61:8135–8142. 2001.PubMed/NCBI
6	Cunha GR, Hayward SW, Wang YZ and Ricke WA: Role of the stromal microenvironment in carcinogenesis of the prostate. Int J Cancer. 107:1–10. 2003. View Article : Google Scholar : PubMed/NCBI
7	Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD and Cunha GR: Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res. 59:5002–5011. 1999.PubMed/NCBI
8	Barclay WW, Woodruff RD, Hall MC and Cramer SD: A system for studying epithelial-stromal interactions reveals distinct inductive abilities of stromal cells from benign prostatic hyperplasia and prostate cancer. Endocrinology. 146:13–18. 2005. View Article : Google Scholar
9	Ricke EA, Williams K, Lee YF, Couto S, Wang Y, Hayward SW, Cunha GR and Ricke WA: Androgen hormone action in prostatic carcinogenesis: stromal androgen receptors mediate prostate cancer progression, malignant transformation and metastasis. Carcinogenesis. 33:1391–1398. 2012. View Article : Google Scholar
10	Tanner MJ, Welliver RC Jr, Chen M, Shtutman M, Godoy A, Smith G, Mian BM and Buttyan R: Effects of androgen receptor and androgen on gene expression in prostate stromal fibroblasts and paracrine signaling to prostate cancer cells. PLoS One. 6:e160272011. View Article : Google Scholar : PubMed/NCBI
11	Lai KP, Yamashita S, Huang CK, Yeh S and Chang C: Loss of stromal androgen receptor leads to suppressed prostate tumourigenesis via modulation of pro-inflammatory cytokines/chemokines. EMBO Mol Med. 4:791–807. 2012. View Article : Google Scholar : PubMed/NCBI
12	Li X, Sterling JA, Fan KH, Vessella RL, Shyr Y, Hayward SW, Matrisian LM and Bhowmick NA: Loss of TGF-β responsiveness in prostate stromal cells alters chemokine levels and facilitates the development of mixed osteoblastic/osteolytic bone lesions. Mol Cancer Res. 10:494–503. 2012.
13	Delsite R and Djakiew D: Characterization of nerve growth factor precursor protein expression by human prostate stromal cells: a role in selective neurotrophin stimulation of prostate epithelial cell growth. Prostate. 41:39–48. 1999. View Article : Google Scholar
14	Krygier S and Djakiew D: The neurotrophin receptor p75NTR is a tumor suppressor in human prostate cancer. Anticancer Res. 21:3749–3755. 2001.PubMed/NCBI
15	Festuccia C, Gravina GL, Muzi P, Pomante R, Ventura L, Ricevuto E, Vicentini C and Bologna M: In vitro and in vivo effects of bicalutamide on the expression of TrkA and P75 neurotrophin receptors in prostate carcinoma. Prostate. 67:1255–1264. 2007. View Article : Google Scholar : PubMed/NCBI
16	Rende M, Rambotti MG, Stabile AM, Pistilli A, Montagnoli C, Chiarelli MT and Mearini E: Novel localization of low affinity NGF receptor (p75) in the stroma of prostate cancer and possible implication in neoplastic invasion: an immunohistochemical and ultracytochemical study. Prostate. 70:555–561. 2010.PubMed/NCBI
17	Festuccia C, Vincentini C, di Pasquale AB, Aceto G, Zazzeroni F, Miano L and Bologna M: Plasminogen activator activities in short-term tissue cultures of benign prostatic hyperplasia and prostatic carcinoma. Oncol Res. 7:131–138. 1995.PubMed/NCBI
18	Festuccia C, Angelucci A, Gravina GL, Muzi P, Miano R, Vicentini C and Bologna M: Epithelial and prostatic marker expression in short-term primary cultures of human prostate tissue samples. Int J Oncol. 26:1353–1362. 2005.PubMed/NCBI
19	Sugimoto H, Mundel TM, Kieran MW and Kalluri R: Identification of fibroblast heterogeneity in the tumor microenvironment. Cancer Biol Ther. 5:1640–1646. 2006. View Article : Google Scholar : PubMed/NCBI
20	De Wever O, Demetter P, Mareel M and Bracke M: Stromal myofibroblasts are drivers of invasive cancer growth. Int J Cancer. 123:2229–2238. 2008.PubMed/NCBI
21	Festuccia C, Angelucci A, Gravina G, Eleuterio E, Vicentini C and Bologna M: Bombesin-dependent pro-MMP-9 activation in prostatic cancer cells requires beta1 integrin engagement. Exp Cell Res. 280:1–11. 2002. View Article : Google Scholar : PubMed/NCBI
22	Festuccia C, Dolo V, Guerra F, et al: Plasminogen activator system modulates invasive capacity and proliferation in prostatic tumor cells. Clin Exp Metastasis. 16:513–528. 1998. View Article : Google Scholar : PubMed/NCBI
23	Schor SL, Schor AM and Rushton G: Fibroblasts from cancer patients display a mixture of both foetal and adult-like phenotypic characteristics. J Cell Sci. 90:401–407. 1988.PubMed/NCBI
24	Reinertsen T, Halgunset J, Viset T, Flatberg A, Haugsmoen LL and Skogseth H: Gene expressional changes in prostate fibroblasts from cancerous tissue. APMIS. 120:558–571. 2012. View Article : Google Scholar : PubMed/NCBI
25	Cifone MG, Botti D, Festuccia C, Napolitano T, del Grosso E, Cavallo G, Chessa MA and Santoni A: Involvement of phospholipase A2 activation and arachidonic acid metabolism in the cytotoxic functions of rat NK cells. Cell Immunol. 148:247–258. 1993. View Article : Google Scholar : PubMed/NCBI
26	Ayala G, Tuxhorn JA, Wheeler TM, et al: Reactive stroma as a predictor of biochemical- free recurrence in prostate cancer. Clin Cancer Res. 9:4792–4801. 2003.PubMed/NCBI
27	McAlhany SJ, Ayala GE, Frolov A, et al: Decreased stromal expression and increased epithelial expression of WFDC1/ps20 in prostate cancer is associated with reduced recurrence-free survival. Prostate. 61:182–191. 2004. View Article : Google Scholar
28	Orimo A, Gupta PB, Sgroi DC, et al: Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell. 121:335–348. 2005. View Article : Google Scholar
29	Rowley DR: What might a stromal response mean to prostate cancer progression? Cancer Metastasis Rev. 17:411–419. 1998. View Article : Google Scholar : PubMed/NCBI
30	Tuxhorn JA, McAlhany SJ, Dang TD, Ayala GE and Rowley DR: Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model. Cancer Res. 62:3298–3307. 2002.PubMed/NCBI
31	Thalmann GN, Rhee H, Sikes RA, Pathak S, Multani A, Zhau HE, Marshall FF and Chung LW: Human prostate fibroblasts induce growth and confer castration resistance and metastatic potential in LNCaP cells. Eur Urol. 58:162–171. 2009. View Article : Google Scholar : PubMed/NCBI
32	Goetz JG, Minguet S, Navarro-Lérida I, Lazcano JJ, Samaniego R, Calvo E, et al: Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis. Cell. 146:148–163. 2011. View Article : Google Scholar : PubMed/NCBI
33	Giatromanolaki A, Koukourakis MI, Koutsopoulos A, Mendrinos S and Sivridis E: The metabolic interactions between tumor cells and tumor-associated stroma (TAS) in prostatic cancer. Cancer Biol Ther. 13:Nov 1–2012, (Epub ahead of print).
34	Freeman MR, Yang W and Di Vizio D: Caveolin-1 and prostate cancer progression. Adv Exp Med Biol. 729:95–110. 2012. View Article : Google Scholar : PubMed/NCBI
35	Giannoni E, Taddei ML, Parri M, Bianchini F, Santosuosso M, Grifantini R, Fibbi G, Mazzanti B, Calorini L and Chiarugi P: EphA2-mediated mesenchymal-amoeboid transition induced by endothelial progenitor cells enhances metastatic spread due to cancer-associated fibroblasts. J Mol Med (Berl). Aug 19–2012, (Epub ahead of print).
36	Franco OE, Shaw AK, Strand DW and Hayward SW: Cancer associated fibroblasts in cancer pathogenesis. Semin Cell Dev Biol. 21:33–39. 2010. View Article : Google Scholar : PubMed/NCBI
37	Daja MM, Niu X, Zhao Z, Brown JM and Russell PJ: Characterization of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in prostate cancer cell lines. Prostate Cancer Prostatic Dis. 6:15–26. 2003. View Article : Google Scholar : PubMed/NCBI
38	Wilson MJ, Sellers RG, Wiehr C, Melamud O, Pei D and Peehl DM: Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells. J Cell Physiol. 191:208–216. 2002. View Article : Google Scholar
39	Zhang J, Jung K, Lein M, Kristiansen G, Rudolph B, Hauptmann S, Schnorr D, Loening SA and Lichtinghagen R: Differential expression of matrix metalloproteinases and their tissue inhibitors in human primary cultured prostatic cells and malignant prostate cell lines. Prostate. 50:38–45. 2002. View Article : Google Scholar